Next 10 |
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentat...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due t...
SAN CARLOS, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. (“Apexigen”), a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, today announced that Apexigen’s Manageme...
Clinical-stage biopharmaceutical company Apexigen announced Wednesday the appointment of William Duke as its new chief financial officer, effective immediately. Duke joins Apexigen from Kaleido, where he served as CFO and was instrumental in leading the successful complet...
SAN CARLOS, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. (“Apexigen”), a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, today announced the appointment of William Duke...
- Data from the Parker Institute for Cancer Immunotherapy and Cancer Research Institute multi-center Phase 2 PRINCE trial demonstrated that novel circulating and tumor biomarkers may be predictive of overall survival - - Identified distinct immune responses and biomarkers in...
Thoma Bravo is acquiring Anaplan for $10.7 billion or $66 per share in cash. Thoma Bravo agreed to pay 18 times trailing sales and 14 times Jan 2023 expected revenue of $746 million. Mill Road Capital urges Big Lots to sell itself. For further details see: Merger Arbitra...
Do You Have These Health Care Stocks On Your Watchlist Today? Health care stocks have long been a popular segment of the stock market among investors. Regardless of geopolitical sentiments or the state of the economy, the industry would still be relevant given its importance to ...
Apexigen is going public on Nasdaq via a business combination agreement with SPAC Brookline Capital Acquisition (NASDAQ:BCAC), a special purpose acquisition company. Upon closing of the transaction, Brookline Capital will be renamed Apexigen Inc., and the combined company expects to list on N...
- Healthcare institutional investors and insiders commit $15 million through private investment in public equity (“PIPE”) - - Lincoln Park Capital has committed to purchase up to $50 million of common stock - - Proceeds to advance the Phase 2 deve...
News, Short Squeeze, Breakout and More Instantly...
Bison Capital Acquisition Corp. Company Name:
BCAC Stock Symbol:
NASDAQ Market:
SAN CARLOS, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. (“Apexigen”), a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, today announced that Apexigen’s Manageme...
SAN CARLOS, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. (“Apexigen”), a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, today announced the appointment of William Duke...
- Data from the Parker Institute for Cancer Immunotherapy and Cancer Research Institute multi-center Phase 2 PRINCE trial demonstrated that novel circulating and tumor biomarkers may be predictive of overall survival - - Identified distinct immune responses and biomarkers in...